Sequential combination therapy with flavopiridol and autocatalytic caspase-3 driven by amplified hTERT promoter synergistically suppresses human ovarian carcinoma growth in vitro and in mice.
about
Downregulation of SASH1 correlates with tumor progression and poor prognosis in ovarian carcinoma.Targeting Cyclin-Dependent Kinases in Ovarian Cancer.Construction of a novel vector expressing Survivin-shRNA and fusion suicide gene yCDglyTK and its application in inhibiting proliferation and migration of colon cancer cells.Therapeutic effect of targeted Fas-expressing adenoviruses method combining γδ T cells in a mouse model of human ovarian carcinoma.
P2860
Sequential combination therapy with flavopiridol and autocatalytic caspase-3 driven by amplified hTERT promoter synergistically suppresses human ovarian carcinoma growth in vitro and in mice.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Sequential combination therapy ...... a growth in vitro and in mice.
@ast
Sequential combination therapy ...... a growth in vitro and in mice.
@en
Sequential combination therapy ...... a growth in vitro and in mice.
@nl
type
label
Sequential combination therapy ...... a growth in vitro and in mice.
@ast
Sequential combination therapy ...... a growth in vitro and in mice.
@en
Sequential combination therapy ...... a growth in vitro and in mice.
@nl
prefLabel
Sequential combination therapy ...... a growth in vitro and in mice.
@ast
Sequential combination therapy ...... a growth in vitro and in mice.
@en
Sequential combination therapy ...... a growth in vitro and in mice.
@nl
P2093
P2860
P1476
Sequential combination therapy ...... a growth in vitro and in mice.
@en
P2093
P2860
P2888
P356
10.1186/S13048-014-0121-3
P577
2014-12-21T00:00:00Z
P6179
1032826719